The whole ccRCC and FTO story is complex and evolving. Ultimately, while papers can give you clues as to what is going on and the likelihood that Zantrene will be a useful drug for ccRCC it will be how Zantrene performs in both cellular and animal models that matters. We are gathering this data and will know what approaches and combinations are best for using Zantrene.
Pillar 1 - FTO (new thread), page-1767
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |